InvestorsHub Logo

jour_trader

11/03/22 9:25 AM

#375171 RE: imanjen13 #375170

Oftentimes there is no correlation as their biggest CNS drug isn’t Adderall. However, Adderall was specifically called out in favorable light in both volume and margin profile. That is good news to Elite.

HGilS

11/03/22 9:29 AM

#375172 RE: imanjen13 #375170

They did report that increase in revenue was from adderall so the other cns went down.

This may also except lain why they do not want to stop current contract with elite.

The ELTP King

11/03/22 3:26 PM

#375184 RE: imanjen13 #375170

Lannett has been reporting overall CNS revenue declines for a while now.

And EVERY time Elite continues to set new quarterly revenue records.

Why? Because Lannett's CNS sales include Concerta which is struggling.

So the pattern has been the LOWER Lannett's CNS revenues, the HIGHER Elite's revenues.

You also have to take into account Elite has like FREAKING 10 other drugs they sell which have also been selling better.

Not to put a damper on the Adderall report from LCI, sales of CNS drugs for Lannett were actually down $2M from the comparative quarter in 2021. Hopefully the shortfall was from central nervous drugs other than the Adderall they sell. Hard to catch a friggin break here it seems.




.